FLC CAPITAL ADVISORS – Abbott Laboratories Transaction History
FLC CAPITAL ADVISORS portfolio value:
$542,000
portfolio value
FLC CAPITAL ADVISORS quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +0.43% | 24 shares | -64K | $96.76 | 5.60K |
Q2 2022 | share | Decrease | -0.82% | -46 shares | -60K | $108.65 | 5.57K |
Q1 2022 | share | 0.00% | 0 shares | -126K | $118.36 | 5.62K | |
Q4 2021 | share | 0.00% | 0 shares | 128K | $141 | 5.62K | |
Q3 2021 | share | 0.00% | 0 shares | 12K | $117.68 | 5.62K | |
Q2 2021 | share | Increase | +0.72% | 40 shares | -17K | $115.05 | 5.62K |
Q1 2021 | share | 0.00% | 0 shares | 58K | $118.49 | 5.58K | |
Q4 2020 | share | 0.00% | 0 shares | 6K | $107.81 | 5.58K | |
Q3 2020 | share | Increase | +5.48% | 290 shares | 113K | $106.81 | 5.58K |
Q2 2020 | share | Decrease | -7.61% | -436 shares | 37K | $89.39 | 5.29K |
Q1 2020 | share | 0.00% | 0 shares | -43K | $76.84 | 5.73K | |
Q4 2019 | share | Decrease | -14.86% | -1K shares | -65K | $84.23 | 5.73K |
Q3 2019 | share | Decrease | -15.39% | -1.22K shares | -114K | $80.81 | 6.73K |
Q2 2019 | share | Increase | +11.34% | 810 shares | 106K | $80.92 | 7.95K |
Q1 2019 | share | Increase | +51.61% | 2.43K shares | 230K | $76.6 | 7.14K |
Q4 2018 | share | Increase | 0.00% | 4.71K shares | 341K | $68.98 | 4.71K |